B C Low
Overview
Explore the profile of B C Low including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang T, Pan C, Low B
Oncogene
. 2017 Jan;
36(22):3178-3192.
PMID: 28092672
Simultaneous hyperactivation of stress-activated protein kinase/c-Jun N-terminal protein kinase (SAPK/JNK) and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signaling cascades has been reported in carcinogenesis. However, how they are integrated...
2.
Poole M, Low B
J Youth Adolesc
. 2013 Dec;
11(1):49-63.
PMID: 24310647
This article examines some of the major variables associated with the "staying" and "leaving" process, particularly as it operates similarly or differentially for male and female adolescents. Sixty attitude statements...
3.
Chew T, Liu X, Liu L, Spitsbergen J, Gong Z, Low B
Oncogene
. 2013 Jul;
33(21):2717-27.
PMID: 23812423
RAS and Rho small GTPases are key molecular switches that control cell dynamics, cell growth and tissue development through their distinct signaling pathways. Although much has been learnt about their...
4.
Wei X, Han B, Zhang J, Liu X, Tan C, Jiang Y, et al.
BMC Syst Biol
. 2011 Jul;
5:112.
PMID: 21756365
Background: Endothelial permeability is involved in injury, inflammation, diabetes and cancer. It is partly regulated by the thrombin-, histamine-, and VEGF-mediated myosin-light-chain (MLC) activation pathways. While these pathways have been...
5.
Ma X, Wang R, Tan C, Jiang Y, Lu T, Rao H, et al.
Mol Pharm
. 2010 Aug;
7(5):1545-60.
PMID: 20712327
Multitarget agents have been increasingly explored for enhancing efficacy and reducing countertarget activities and toxicities. Efficient virtual screening (VS) tools for searching selective multitarget agents are desired. Combinatorial support vector...
6.
Liu X, Ma X, Tan C, Jiang Y, Go M, Low B, et al.
J Chem Inf Model
. 2009 Aug;
49(9):2101-10.
PMID: 19689138
Abl promotes cancers by regulating cell morphogenesis, motility, growth, and survival. Successes of several marketed and clinical trial Abl inhibitors against leukemia and other cancers and appearances of reduced efficacies...
7.
Ma X, Wang R, Yang S, Li Z, Xue Y, Wei Y, et al.
J Chem Inf Model
. 2008 Jun;
48(6):1227-37.
PMID: 18533644
Virtual screening performance of support vector machines (SVM) depends on the diversity of training active and inactive compounds. While diverse inactive compounds can be routinely generated, the number and diversity...
8.
Zhu S, Korzh V, Gong Z, Low B
Oncogene
. 2007 Sep;
27(11):1580-9.
PMID: 17873909
RhoA small GTPase, as a key regulator for actin cytoskeletal rearrangement, plays pivotal roles during morphogenesis, cytokinesis, phagocytosis and cell migration, but little is known about its signaling mechanism that...
9.
Zhou Y, Guy G, Low B
Oncogene
. 2005 Dec;
25(16):2393-408.
PMID: 16331259
Changes in cell morphology are linked to many cellular events including cytokinesis, differentiation, migration and apoptosis. We recently showed that BNIP-Salpha induced cell rounding that leads to apoptosis via its...
10.
Lua B, Low B
Biochem Soc Trans
. 2004 Oct;
32(Pt 6):1110-2.
PMID: 15506981
Cells undergo dynamic changes in morphology or motility during cellular division and proliferation, differentiation, neuronal pathfinding, wound healing, apoptosis, host defense and organ development. These processes are controlled by signalling...